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Abstract
Tyrosinase, which catalyzes both the hydroxylation of tyrosine and consequent oxidation of L-DOPA to form melanin in
melanocytes, is also expressed in the brain, and oxidizes L-DOPA and dopamine. Replacement of dopamine synthesis by
tyrosinase was reported in tyrosine hydroxylase null mice. To examine the potential benefits of autograft cell
transplantation for patients with Parkinson’s disease, tyrosinase-producing cells including melanocytes, were transplanted
into the striatum of hemi-parkinsonian model rats or mice lesioned with 6-hydroxydopamine. Marked improvement in
apomorphine-induced rotation was noted at day 40 after intrastriatal melanoma cell transplantation. Transplantation of
tyrosinase cDNA-transfected hepatoma cells, which constitutively produce L-DOPA, resulted in marked amelioration of the
asymmetric apomorphine-induced rotation in hemi-parkinsonian mice and the effect was present up to 2 months.
Moreover, parkinsonian mice transplanted with melanocytes from the back skin of black newborn mice, but not from albino
mice, showed marked improvement in the apomorphine-induced rotation behavior up to 3 months after the
transplantation. Dopamine-positive signals were seen around the surviving transplants in these experiments. Taken
together with previous studies showing dopamine synthesis and metabolism by tyrosinase, these results highlight
therapeutic potential of intrastriatal autograft cell transplantation of melanocytes in patients with Parkinson’s disease.
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Introduction
Similar to the peripheral melanin biosynthetic pathway, the
multifunctional enzyme tyrosinase (EC 1.14.18.1; monophenol
monooxygenase) in the brain catalyzes the conversion of L-
tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA) and oxidizes
L-DOPA to form dopa quinone, which is a melanin precursor. In
addition, it is known that tyrosinase also oxidizes dopamine (DA)
to rapidly form melanin via the DA quinone [1]. Several studies
have demonstrated the expression, promoter activity of tyrosinase,
and tyrosinase-like enzyme activity in the substantia nigra [2,3,4].
Furthermore, a previous study has demonstrated that DA quinone,
the formation of which is enhanced by tyrosinase, inactivates
tyrosine hydroxylase (TH) [5]. On the other hand, supplement of
DA synthesis by tyrosinase has been reported in TH null mice [6].
These findings imply that tyrosinase may be involved in
catecholaminergic cell function, and that the activity of this
enzyme may contribute to the pathogenesis or complementary
reaction associated with Parkinson’s disease (PD).
The aim of present study was to investigate the effects of
transplantation of tyrosinase-producing cells in parkinsonian
models. Different approaches were used for this purpose. 1)
B16-F1 melanoma cells or non-melanogenic cells transfected with
tyrosinase gene, as tyrosinase-producing cells, were transplanted
into the striatum of hemi-parkinsonian models lesioned with 6-
hydroxydopamine (6-OHDA). Following these approaches, we
then examined changes in apomorphine-induced contralateral
rotation behavior and in striatal expression of DA and tyrosinase.
2) Finally, we examined transplantation of melanocytes from the
back skin, as clinically available tyrosinase-expressing cells, into the
striatum of hemi-parkinsonian mice.
Materials and Methods
Materials and Animals
The chemicals listed below were purchased from Sigma-Aldrich
(St. Louis, MO): 6-OHDA hydrobromide, apomorphine, dibutyryl
cAMP, insulin, bovine serum albumin, ethanolamine, phos-
phoethanolamine, sodium selenite, gentamicin sulfate, amphoter-
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icin B and 3,39-diaminobenzidine (DAB). Male Sprague-Dawley
rats weighing 280–300 g (9-weeks-old) and male ICR mice
weighing 30–35 g (8-weeks-old) were purchased from Charles
River Japan, Yokohama, Japan and used to establish an animal
model of hemi-parkinsonism. Newborn albino ICR mice or black
C57BL mice were used for primary cultures of melanocytes. All
animal procedures were in strict accordance with the Guideline for
Animal Experiments of Okayama University Advanced Science
Research Center, and were approved by the Animal Care and Use
Committee of Okayama University Advanced Science Research
Center. Special interest was taken to minimize the number of
animals used in this research.
Hemi-parkinsonian Rats
Unilateral nigrostriatal dopaminergic lesions were generated
using the method described previously with some modifications
[7]. Briefly, 6-OHDA hydrobromide (5 mg in 2 ml saline contain-
ing 0.1% ascorbate) was injected at two sites (5 mg/site) in the right
medial forebrain bundle of male Sprague-Dawley rats (9-weeks-
aged) under pentobarbital anesthesia (50 mg/kg, i.p.) at the
following coordinates: A 21.0 mm, L +1.8 mm, V +8.5 mm; A
21.4 mm, L +1.5 mm, V +8.0 mm from the bregma according to
the atlas of the rat brain (upper incisor bar set 5.0 mm above the
interaural line [8]). Sham-operated control rats were injected with
the same volume of saline containing 0.1% ascorbate.
Intrastriatal Injection of Liposome-entrapped Tyrosinase
At 14 and 34 days after injection of 6-OHDA into the right
medial forebrain bundle, apomorphine (0.1 mg/kg, s.c.) rotation
test was performed to confirm the lesion of nigrostriatal
dopaminergic pathway. Rats that exhibited asymmetric rotation
behavior towards the contralateral side of .10 turns/2 min at
10 min after injection of apomorphine were selected for the
subsequent tyrosinase replacement study. Liposome-entrapped
mushroom tyrosinase [9,10] (19.2 U/4 mg/4 ml lipofectin) or
lipofectin alone was injected at two sites (4 ml/site) in the right
lesioned side of the lateral striatum of hemi-parkinsonian rats as
well as sham-operated control rats under pentobarbital anesthesia
(50 mg/kg, i.p.) at the following coordinates: A +0.7 mm, L
+3.0 mm, V +4.0 mm and +5.0 mm from the bregma according
to the atlas of the rat brain (upper incisor bar set 3.9 mm below
the interaural line; [11]) at 38 days after 6-OHDA lesioning.
Apomorphine (0.1 mg/kg, s.c.) rotation test was performed at 3, 6
and 12 days after tyrosinase injection. Rotation behavior towards
the contralateral side over a 2-min period was observed at 10 min
after apomorphine injection.
Intrastriatal Transplantation of B16-F1 Melanoma Cells
Lesioning by 6-OHDA was confirmed by apomorphine
(0.1 mg/kg, s.c.) rotation test at 16 and 43 days after injection
into the right medial forebrain bundle. Rats that exhibited
asymmetric rotation behavior towards the contralateral side of
.20 turns/5 min at 5 min after apomorphine injection were
selected for the subsequent melanoma cell transplantation. The
mouse B16-F1 melanoma cells (ATCC # CRL-6323, Manassas,
VA) were cultured in Dulbecco’s Modified Eagle Medium
(DMEM; Gibco BRL, Rockville, MD) supplemented with 10%
(v/v) fetal bovine serum (FBS), 4 mM L-glutamine, 100 U/ml
penicillin and 100 mg/ml streptomycin. Under pentobarbital
anesthesia (50 mg/kg, i.p.), B16-F1 melanoma cells suspended
with PBS (56105 cells/4 ml PBS) or the same volume of PBS as
control were transplanted at two sites (4 ml/site) in the right lateral
striatum of hemi-parkinsonian rats as well as saline-injected sham-
operated rats at 46 days after 6-OHDA lesioning at the following
coordinates: A +0.7 mm, L +3.0 mm, V +4.0 mm and +5.0 mm
from the bregma according to the atlas of the rat brain (upper
incisor bar set 3.9 mm below the interaural line; [11]). Apomor-
phine (0.1 mg/kg, s.c.) rotation test was performed at 3, 7, 14 and
40 days after B16-F1 melanoma cell transplantation. Rotation
behavior towards contralateral side over a period of 5 min was
examined at 5 min after apomorphine injection.
Hemi-parkinsonian Mice
To prepare hemi-parkinsonian mice, unilateral striatal lesions
were induced by intrastriatal injection of 6-OHDA with some
modification of the previously reported procedure [12]. Ten mg of
6-OHDA in 1 ml of physiological saline containing 0.1% ascorbic
acid was injected into two sites (10 mg 6-OHDA/site) in the right
striatum of male ICR mice under pentobarbital anesthesia
(50 mg/kg, i.p.) at the following coordinates: A +0.7 mm, L
+2.0 mm, V +3.0 mm; A +0.2 mm, L +2.4 mm, V +3.0 mm from
the bregma according to the atlas of the mouse brain (upper
incisor bar set 2.0 mm below the interaural line) [13]. Sham-
operated control mice were injected with the same volume of
saline containing 0.1% ascorbate.
Intrastriatal Transplantation of Tyrosinase Gene-
transfected Hepatoma Cells
After the above mentioned 6-OHDA lesioning in mice,
apomorphine (0.5 mg/kg, s.c.) rotation test was performed at
Days 17 and 24 to confirm the lesion. Mice that exhibited
asymmetric rotation behavior towards the contralateral side of
.30 turns/10 min after apomorphine injection were selected for
subsequent transplantation. HLE cell line, a commonly used
human hepatoma cell line which we first established [14,15,16],
was cultured in DMEM supplemented with 10% FBS and
100 mg/ml kanamycin, and then transfected with human tyrosi-
nase cDNA (HLE/tyrosinase) or empty vector (HLE) as reported
previously [17]. The transfected cells were suspended with PBS
(16106 cells/2 ml), and then transplanted into the right lateral
striatum of hemi-parkinsonian albino mice under pentobarbital
anesthesia (50 mg/kg, i.p.) at 28 days after the 6-OHDA lesioning
at the following coordinate: A +0.5 mm, L +2.0 mm, V +3.0 mm
from the bregma (upper incisor bar set 2.0 mm below the
interaural line) [13]. Apomorphine (0.5 mg/kg, s.c.) rotation test
was performed at 3–77 days after HLE/tyrosinase transplantation.
Rotation behavior towards the contralateral side over a period of
10 min was examined after apomorphine injection.
Intrastriatal Transplantation of Melanocytes
In apomorphine (0.5 mg/kg, s.c.) rotation test at 28 and 44
days after 6-OHDA injection conducted to confirm 6-OHDA-
induced lesion, albino ICR mice that exhibited asymmetric
rotation behavior towards the contralateral side of .30 turns/
10 min after injection were selected for the subsequent
transplantation of melanocytes. Melanocytes were harvested
from the back of newborn albino ICR mice or black C57BL
mice by filtration through 40 mm-nylon mesh according to the
previously reported method [18,19], and then cultured in
melanocyte culture medium (MDMD: melanoblast-defined
medium with dibutyryl cAMP) consisting of Ham’s F10 medium
(Gibco BRL) supplemented with 10 mg/ml insulin, 1 mg/ml
bovine serum albumin, 1 mM ethanolamine, 1 mM phosphoetha-
nolamine, 10 nM sodium selenite, 50 mg/ml gentamicin sulfate,
0.25 mg/ml amphotericin B and 0.5 mM dibutyryl cAMP.
Melanocytes from albino or black mice suspended with medium
(36105 cells/2 ml) were transplanted into the right lateral
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striatum of hemi-parkinsonian albino mice as well as saline-
injected sham-operated controls under pentobarbital anesthesia
(50 mg/kg, i.p.) on Day 48 after 6-OHDA lesioning at the
following coordinate: A +0.5 mm, L +2.0 mm, V +3.0 mm
from the bregma (upper incisor bar set 2.0 mm below the
interaural line) [13]. Apomorphine (0.5 mg/kg, s.c.) rotation test
was performed at 3–86 days after melanocyte transplantation.
The rotation behavior towards contralateral side over a period
of 10 min was conducted after apomorphine injection.
Immunohistochemistry of Hemi-parkinsonian Brain
Animals were transcardially perfused with 4% paraformalde-
hyde at 3 or 14 days after tyrosinase lipofection, at 52 days after
intrastriatal B16-F1 melanoma cell transplantation, at 80 days
after HLE/tyrosinase transplantation, and at 88 days (12 weeks)
after intrastriatal melanocyte transplantation. The perfused brains
were removed and post-fixed for 24 h in 4% paraformaldehyde.
Following cryoprotection in 15% sucrose in PB for 48 h, the brains
were snap-frozen with powdered dry ice and 20-mm-thick coronal
sections were cut on a cryostat at the mid-striatal level through the
tyrosinase-injected area or around the transplant and at level of
the substantia nigra pars compacta.
Striatal tyrosinase- or DA-immunoreactivity in transplanted
animals was visualized by fluorescent immunohistochemistry using
goat polyclonal anti-tyrosinase antibody (dilution 1:200, Santa
Cruz Biotechnology, Santa Cruz, CA) or rabbit polyclonal anti-
DA antibody (dilution 1:200, Chemicon International, Temecula,
CA) and FITC-conjugated anti-goat IgG or rhodamine-conjugat-
ed anti-rabbit IgG secondary antibody (Chemicon), respectively.
Double immunofluorescence staining of tyrosinase and TH or glial
fibrillary acidic protein (GFAP) in mid-striatal or nigral sections of
hemi-parkinsonian rats were also performed using anti-tyrosinase
antibody (dilution 1:200, Santa Cruz Biotechnology) and rabbit
anti-TH polyclonal antibody (dilution 1:10,000, Protos Biotech,
New York, NY) or rabbit anti-GFAP antibody (1:1,000; Dako
Cytomation, Glostrup, Denmark). Sections were also stained by
hematoxylin-eosin to visualize the transplant. Tyrosinase-positive
(green) and DA-positive, TH-positive or GFAP-positive (red)
immunofluorescence signals were analyzed under a fluorescence
microscope (Olympus BX50-FLA, Tokyo) using a mercury lamp
through a 470–490 nm or 530–550 nm, band-pass filter to excite
FITC or rhodamine, respectively. Light emitted from FITC or
rhodamine was collected through 515–550 nm band-pass filter or
590 nm long-pass filter, respectively.
TH-immunoreactivity (IR) was also visualized in striatal or
nigral sections of transplanted animals by standard free-floating
immunohistochemistry with chromogen DAB. The sections were
then incubated with anti-TH rabbit polyclonal antibody (dilution
1:10,000, Protos Biotech, New York, NY) overnight at 4uC,
followed by incubation for 2 h at room temperature with
biotinylated goat anti-rabbit IgG secondary antibody (dilution
1:1,000; Vector Laboratories, Burlingame, CA). After washing, the
sections were incubated with avidin-biotin peroxidase complex
(dilution 1:2,000, Vector) for 1 h at room temperature. TH-IR
was visualized by DAB, nickel, and hydrogen peroxide. Nuclear
counter-staining was performed with methylgreen.
The relative density of tyrosinase-, DA- or TH-IR was semi-
quantified using a microscope in at x200 magnification for the
mid-striatum and x100 magnification for the substantia nigra pars
compacta and a Macintosh computer-based image analysis system
(NIH Image J 1.44k) [20]. For precise measurement, the mid-
striatum was divided into two areas of lateral striatum and medial
striatum. The relative density of immunopositive signals in the
lateral striatum was quantitatively measured. The boundary
between the substantia nigra pars compacta and ventral tegmental
area was defined by a line extending dorsally from the most medial
boundary of the cerebral peduncle.
Fluorescent Immunocytochemistry of Tyrosinase Gene-
transfected Cells
Cultured HLE cells transfected with tyrosinase cDNA (HLE/
tyrosinase) on 4-chamber culture slides (Becton Dickinson,
Franklin lakes, NJ) were fixed with 4% paraformaldehyde.
Tyrosinase- or L-DOPA-IR was detected by immunohistochem-
istry using goat polyclonal anti-tyrosinase antibody (dilution 1:200,
Santa Cruz Biotechnology) or rabbit polyclonal anti-L-DOPA
antibody (dilution 1:200, Chemicon) and FITC-conjugated anti-
goat IgG or rhodamine-conjugated anti-rabbit IgG secondary
antibody (Chemicon), respectively. The nuclei were counterstained
with 10 mg/ml Hoechst 33342 (Invitrogen, San Diego, CA).
Immunofluorescence signals were analyzed under a fluorescence
microscope as mentioned above.
Measurement of DA and its Metabolites in Striatum of
Hemi-parkinsonian Mice
Striatal tissue of hemi-parkinsonian mice was removed at 80
days after transplantation of HLE cells transfected with tyrosinase
cDNA (HLE/tyrosinase). The contents of L-DOPA, DA and its
metabolites, 3,4-dihydroxyphenyl acetic acid (DOPAC) and
homovanillic acid (HVA), were measured using high-performance
liquid chromatography with an electrochemical detector (HPLC-
ECD) as described previously [7]. The striatal tissue was
homogenized with 5 volumes of 200 mM ice-cold perchloric acid
containing 10 mM EDTA. After centrifugation (11,7506g, for
20 min at 4uC), the supernatant was filtered (0.45 mm) and then
injected directly into a HPLC-ECD (Tosoh Co., Tokyo, Japan).
The HPLC system consisted of a delivery pump (PX-8020, Tosoh
Co.) and an analytical column (EICOMPAK SC-5ODS,
3.0 mm6150 mm, Eicom Co., Kyoto, Japan). An electrochemical
detector (EC-8020, Tosoh Co.) with glassy carbon was used with a
voltage setting of 700 mV and an Ag/AgCl reference electrode. A
mobile phase containing 0.1 M citrate-sodium acetate buffer
(pH 3.5), methanol (17% v/v), EDTA-2Na, and sodium 1-
octanesulfonate was infused at a flow rate of 0.6 ml/min.
Statistical Analysis
Values were expressed as means 6 SEM. Differences between
groups were examined for statistical significance by one-way or
two-way analysis of variance (ANOVA), followed by post hoc
Fisher’s PLSD multiple comparison test. A P value less than 0.05
was considered statistically significant.
Results
Expression of Tyrosinase in the Basal Ganglia of Hemi-
parkinsonian Rats
We examined changes in tyrosinase expression in the basal
ganglia of hemi-parkinsonian rats. Tyrosinase-positive signals were
increased on the lesioned side of the substantia nigra, but
decreased on the lesioned side of the striatum at 4 weeks after 6-
OHDA injection (Figure 1 and Figure S1B). The increase in nigral
tyrosinase expression implies complementary DA synthesis by
tyrosinase in the parkinsonian models we used as well as TH null
mice [6].
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Intrastriatal Injection of Liposome-entrapped Tyrosinase
in Hemi-parkinsonian Rats
Asymmetric rotation behavior towards the contralateral side
was seen in 6-OHDA-injected hemi-parkinsonian model rats after
apomorphine injection. The apomorphine-induced rotation be-
havior of hemi-parkinsonian model was significantly but tran-
siently improved at 3 and 6 days after replacement of liposome-
entrapped mushroom tyrosinase (19.2 U/4 mg/4 ml lipofectin X2)
into the lesioned side of the striatum (Figure S1A and Movie S1).
Increased expression of tyrosinase-positive signals on the injected
(lesioned) side of the striatum was lasted at 14 days after injection
of liposome-entrapped tyrosinase in both sham-operated and
hemi-parkinsonian animals compared with the injected side in
lipofectin-injected mice or the non-injected (control) side in each
tyrosinase-injected mice (Figure S1B). Marked increase in DA-IR
was also noted on the injected side of the striatum at 14 days after
tyrosinase injection, especially in hemi-parkinsonian rats (Figure
S1C). However, the intrastriatal injection of liposome-entrapped
tyrosinase showed no effects on TH-IR in the basal ganglia (Figure
S2).
Intrastriatal Transplantation of B16-F1 Melanoma Cells in
Hemi-parkinsonian Rats
The apomorphine-induced rotation behavior towards the
contralateral side was significantly and markedly improved in
hemi-parkinsonian rats at days 7 and 14 after intrastriatal
transplantation of B16-F1 melanoma cells (56105 cells/4 ml PBS
X2), and such effect persisted up to 40 days after cell
transplantation (Figure 2A and Movie S2). Dark melanoma cells
were observed in the needle tract on the injected side of the
striatum in both sham-operated and hemi-parkinsonian animals
after cell transplantation (Figure 2B and Figure S3). The
intrastriatal transplantation of B16-F1 melanoma cells significantly
and markedly increased DA-IR around the surviving transplant on
the injected side of the striatum at 52 days after transplantation in
both sham-operated and hemi-parkinsonian animals (Figure 2C),
Figure 1. Expression of tyrosinase in the basal ganglia of hemi-parkinsonian rats. (A) Immunofluorescence signals using anti-tyrosinase
antibody (green) and anti-GFAP antibody (red) in the mid-striatum on the control side or lesioned side of hemi-parkinsonian rats and sham-operated
controls at 4 weeks after lesioning by 6-OHDA injection. (B) Double immunofluorescence staining using anti-tyrosinase antibody (green) and anti-TH
antibody (red) in the substantia nigra of the intact side or lesioned side of hemi-parkinsonian rats and sham-operated controls. (A, B) Each right panel
shows means integrated density of tyrosinase-IR 6 SEM (n= 3). *p,0.05, **p,0.01 vs. intact side of each treated group. ##p,0.01 vs. side-matched
sham-operated control group.
doi:10.1371/journal.pone.0065983.g001
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without affecting TH-IR in the striatum and substantia nigra
(Figure S3).
Intrastriatal Transplantation of Tyrosinase Gene-
transfected Hepatoma Cells in Hemi-parkinsonian Mice
Furthermore, non-melanogenic human hepatoma HLE cells
transfected with tyrosinase cDNA (HLE/tyrosinase) were trans-
planted into the striatum of hemi-parkinsonian mice. Intrastriatal
transplantation of empty vector-transfected non-melanogenic
HLE cells that produce no tyrosinase or L-DOPA did not show
any effects on apomorphine-induced rotation behavior towards
the control side in hemi-parkinsonian model mice (Figure 3A, 3B
and Movie S3). In the group transplanted with tyrosinase cDNA-
transfected HLE cells that constitutively produced L-DOPA
(Figure 3A), however, the apomorphine-induced rotation behavior
towards the contralateral side was markedly improved at 14 days
and up to 77 days (2 months) after transplantation (Figure 3B and
Movie S3). High tyrosinase- and DA-IR was detected in surviving
tyrosinase-expressing transplant on the injected side of the
striatum of hemi-parkinsonian mice at 80 days after transplanta-
tion (Figure 3D). In the lesioned-side of the striatum where TH-IR
was reduced, dark melanin granules were observed in the surviving
transplanted tyrosinase cDNA-transfected HLE cells (Figure 3C).
The level of L-DOPA was significantly increased in the injected
side of the striatum at 80 days after intrastriatal HLE/tyrosinase
transplantation, compared with naive or empty vector-transfected
HLE cell-transplanted hemi-parkinsonian mice (Figure 3E). Fur-
thermore, HLE/tyrosinase transplantation rectified the reduced
levels of DA and DOPAC on the lesioned side of the striatum in
hemi-parkinsonian animals.
Intrastriatal Transplantation of Primary Cultured
Melanocytes in Hemi-parkinsonian Mice
In hemi-parkinsonian mice transplanted with primary cul-
tured melanocytes obtained from the back skin of newborn
C57BL black mice (tyrosinase activity: approx. 49 U/mg
protein), the apomorphine-induced rotation behavior towards
the contralateral side was markedly improved at 7–14 days up
to 12 weeks (3 months) after transplantation, compared with
transplanted group with melanocytes from albino ICR mice
(tyrosinase activity: null) or control group injected with the
medium only (Figure 4A and Movie S4). Even transplantation
with melanocytes obtained from albino ICR mice had beneficial
effects, though not significantly, on asymmetric rotation
Figure 2. Effects of intrastriatal transplantation of B16-F1 melanoma cells in hemi-parkinsonian rats. (A) Rotation behavior towards
contralateral side for 5 min at 5 min after injection of apomorphine (0.1 mg/kg, s.c.) was tested at 3, 7, 14 and 40 days after transplantation of B16-F1
melanoma cell (56105 cells/4 ml PBS X2) into the right lateral striatum of hemi-parkinsonian rats or sham-operated controls. Values are means 6 SEM
of 3–4 rats. *p,0.05, **p,0.01, ***p,0.001 vs. each sham-PBS, ++p,0.01, +++p,0.001 vs. each 6-OHDA-PBS, ##p,0.01, ###p,0.001 vs. each pre-
transplantation of B16-F1 cells. Representative photographs of hematoxylin-eosin-staining (B) and DA-IR (C) of the striatal area around the transplant
at 52 days after intrastriatal transplantation of B16-F1 melanoma cells in hemi-parkinsonian rats and sham-operated controls. (C) Lower panel shows
means integrated density of DA-IR 6 SEM (n= 3–4). **p,0.0001 vs. control side of each treated group. ##p,0.0001 vs. side-matched PBS-injected
control group.
doi:10.1371/journal.pone.0065983.g002
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behavior. Surviving melanocytes containing dark melanin
granules were observed on the injected side of the striatum in
hemi-parkinsonian mice transplanted with melanocytes from
black mice, but not from albino tyrosinase-null ICR mice
(Figure 4B). Dramatic increases in expression of tyrosinase-IR
(Figures 4C and 5A) and DA-positive signals (Figures 4D and
5B) were detected around the surviving transplant on the
lesioned side of the striatum at 88 days (3 months) after the
transplantation of melanocytes from black mice in hemi-
parkinsonian animals. However, the transplantation of melano-
cytes showed no effects on TH-IR both in the striatum and
substantia nigra (Figure S4).
Discussion
The main findings of this study are: (1) transplantation of
tyrosinase-producing cells into the striatum resulted in marked
amelioration of the apomorphine-induced abnormal rotation
behavior with increase in L-DOPA and DA in hemi-parkinsonian
animal models, and (2) intrastriatal transplantation of melanocytes
from the back skin as clinically available tyrosinase-expressing cells
showed lasting improvement in the apomorphine-induced rotation
behavior in hemi-PD model mice, with increase in DA-positive
signals around the surviving transplants.
The melanin-synthesizing enzyme tyrosinase is expressed in the
brain [2,3,4]. In impaired dopaminergic neuronal system,
complementary DA synthesis by tyrosinase was reported in TH
null mice [6]. In the present study, tyrosinase-positive signals were
increased on the lesioned side of the substantia nigra pars
compacta in hemi-parkinsonian animals (Figure 1). Therefore,
the increase in tyrosinase in the substantia nigra may be a reaction
to complement TH in the parkinsonian brain. Amicarelli et al.
reported previously that intrastriatal injection of liposome-
entrapped tyrosinase significantly increased the DA level in the
striatum of normal rats [9]. Since the DA-positive signals was
increased up to 14 days after intrastriatal injection of liposome-
entrapped tyrosinase (Figure S1), the ameliorative effect of
liposome-entrapped tyrosinase against dopaminergic dysfunction
could be due to the recovery of reduced DA levels following
tyrosinase replacement. In the present study, furthermore,
intrastriatal transplantation of melanogenic B16-F1 cells or
primary cultured melanocytes from black mice showed marked
improvement in abnormal contralateral rotation behavior in
parkinsonian animals lasting up to 1–3 months after the
transplantation, with significant increase in DA signals around
the surviving transplant (Figures 2, 4 and 5). Freed et al. reported
that B16-C3 melanoma cells transplanted into the striatum of
normal rats expressed TH-immunoreactivity and catecholamine
fluorescence by 3 weeks after transplantation [21]. Although
intrastriatal transplantation of melanogenic retinal pigment
epithelial cells failed to provide clinical benefits in parkinsonian
patients [22], the amount of produced L-DOPA from the
transplant is obscure in the clinical trial. In the present study,
intrastriatal transplantation of non-melanogenic human hepatoma
HLE cells transfected with tyrosinase cDNA (HLE/tyrosinase) into
hemi-parkinsonian mice also markedly improved the asymmetric
rotation behavior at day 14 up to 2 months after transplantation.
The transplanted cells constitutively produced L-DOPA to
increase the levels of L-DOPA and DA in the lesioned side of
the striatum (Figure 3). On the other hand, transplantation of
empty vector-transfected non-melanogenic HLE cells showed no
significant ameliorating effects. Therefore, the therapeutic effects
of transplantation of melanogenic cells into the striatum of hemi-
parkinsonian animals could be explained by their tyrosinase-
expressing properties to replace L-DOPA/DA levels.
Several neurotrophic factors, such as nerve growth factor, brain-
derived neurotrophic factor and glial cell line-derived neurotroph-
ic factor (GDNF), and/or those neurotrophic factors-secreting cell
implants enhance function and survival of transplanted cells as
well as remaining DA neurons in PD models [23,24,25,26,27].
Among these trophic factors, striatal expression of GDNF was
examined, because it exerts neurotrophic and neuroprotective
effects on DA neurons. No changes in GDNF expression were
detected in the extracellular spaces around the melanocyte-
transplants in the striatum of PD model mice (data not shown).
However, it is hard to negate a possibility that the therapeutic
effects of transplanted melanogenic cells in the present study may
be, in part, due to possible trophic factor-secreting property of
implanted cells.
Therapeutic efficacy of cell transplantation approaches for
parkinsonian models or PD patients has been reported in the
studies using various kinds of stem cells, neural precursor cells or
other cells. However, those cell transplantation therapies have
several possible adverse effects such as off-state dyskinesia, immune
rejection and immunosuppressant use in allogeneic implants and
tumor formation in stem cell implants [25,28]. Furthermore,
transplantation of fetal cells or embryonic stem cells has ethical
and social concerns. The effects of intrastriatal transplantation of
melanocytes obtained from the back skin in the present study
imply potentially therapeutic benefits of autograft melanocyte
transplantation in PD patients, because the autograft cell
transplantation can avoid or reduce immunological, ethical and
social concerns.
The transplantation of fetal mesencephalic tissue develops graft-
induced dyskinesia (GID) in a subpopulation of PD patients. The
GID is one of major complications referred to as off-medication
dyskinesia that appears independent of L-DOPA therapy. Even if
the autograft transplantation of melanocytes can reduce some
complications or concerns of cell transplantation therapies, we will
be unable to exclude a possible occurrence of GID in PD patients.
Although mechanisms of GID are still obscure, postsynaptic
supersensitivity prior to transplantation and DA receptor-mediat-
ed signaling may be involved in the development of GID as well as
Figure 3. Effects of intrastriatal transplantation of tyrosinase cDNA-transfected hepatoma HLE in hemi-parkinsonian mice. Human
hepatoma HLE cells transfected with tyrosinase cDNA (HLE/tyrosinase) (16106 cells/2 ml PBS) or empty vector (HLE) were transplanted into the right
(lesioned side) lateral striatum of hemi-parkinsonian albino mice. (A) Double immunostaining of tyrosinase/L-DOPA in cultured human tyrosinase
cDNA-transfected HLE cells. (B) Rotation behavior towards contralateral side over 10 min after injection of apomorphine (0.5 mg/kg, s.c.) was
recorded at 3–77 days after HLE/tyrosinase transplantation. Values are means6 SEM of 4 mice. *p,0.05, **p,0.001 vs. each time-matched sham-HLE
group. +p,0.05 vs. each time-matched 6-OHDA-HLE group. #p,0.01, ##p,0.001 vs. each pre-transplantation of HLE cells. (C–D) Histological
changes in the striatal area around the transplant after transplantation of intrastriatal HLE/tyrosinase into hemi-parkinsonian mice. TH-
immunostaining with nuclear counter-staining using methylgreen (C), tyrosinase-positive IR (D; green) and DA-positive IR (D; red) in the right lateral
striatum around the transplant of hemi-parkinsonian mice at 80 days (12 weeks) after intrastriatal HLE/tyrosinase transplantation. (E) Changes in the
striatal contents of L-DOPA, DA and its metabolites DOPAC and HVA of hemi-parkinsonian mice at 80 days after HLE/tyrosinase transplantation.
Values are means 6 SEM of 6–8 samples from 3–4 mice. *p,0.001, **p,0.0005 compared with the control side of each treated group. #p,0.05,
##p,0.005 compared with side-matched HLE cell-transplanted group.
doi:10.1371/journal.pone.0065983.g003
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L-DOPA-induced dyskinesia [28,29]. Furthermore, contaminated
serotonergic neurons in the fetal tissue graft are thought to cause
GID because GID is attenuated by serotonin 5-HT1A agonist
[30]. However, the transplanted melanogenic cells were not
Figure 4. Effects of intrastriatal transplantation of primary cultured melanocytes in hemi-parkinsonian mice. Melanocytes from albino
(ICR) or black (BL) mice suspended with medium (36105 cells/2 ml) were transplanted into the right lateral striatum of hemi-parkinsonian albino mice
and sham-operated controls at 48 days after 6-OHDA lesioning. (A) Asymmetric rotation behavior towards contralateral side over 10 min after
injection of apomorphine (0.5 mg/kg, s.c.) was recorded at 3–86 days after melanocyte transplantation. Values are means 6 SEM of 3–4 mice.
*p,0.05, **p,0.01, ***p,0.001 vs. each 6-OHDA-medium, +p,0.05, ++p,0.01 vs. each 6-OHDA-melanocytes ICR, #p,0.05, ##p,0.01 vs. each pre-
transplantation of melanocytes. Histological changes in the striatal area around the transplant after intrastriatal melanocyte transplantation into
hemi-parkinsonian mice. Hematoxylin-eosin-staining (B), tyrosinase-positive IR (C), and DA-positive IR (D) in the right lateral striatum around the
transplant of hemi-parkinsonian albino mice and sham-operated controls at 88 days (12 weeks) after intrastriatal transplantation of melanocytes
obtained from albino (ICR) or black (C57BL) mice.
doi:10.1371/journal.pone.0065983.g004
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contaminated with serotonergic neurons, and no apparent
involuntary movements in PD models during at least observation
periods in the present study. Therefore, melanocyte transplanta-
tion may ameliorate postsynaptic supersensitivity prone to develop
GID.
Since a toxic molecule of DA quinone could be generated in the
oxidation of excess DA by tyrosinase, it might be argued that DA
from transplanted tyrosinase-containing melanocytes would be
converted to DA quinones that exert neurotoxicity. However, our
previous studies revealed that tyrosinase could enzymatically and
rapidly oxidize excess amounts of cytosolic DA to form stable
melanin, which may rather prevent the slow progression of cell
damage induced by DA auto-oxidation [17,31]. If DA level in the
striatum was excess, furthermore, the transplanted animals would
show ipsilateral rotation behavior after apomorphine injection. In
fact, sham-operated normal animals transplanted with genetically
tyrosinase-overexpressed HLE cells showed rotation behavior
towards the rather ipsilateral side (Figure 3). However, all
intrastriatal transplantation of tyrosinase-containing cells to
hemi-parkinsonian animals ameliorated the apomorphine-induced
rotation behavior towards the contralateral side, but caused no
involuntary ipsilateral rotation in the present study (Figures 2, 3, 4
and S1). Therefore, the transplantation of tyrosinase-containing
melanocytes in this experiment supplemented DA, but it would
not render DA levels excess in the lesioned-side of the striatum up
to 1–3 months after transplantation. In other words, DA levels
may be well controlled for at least 3 months after the melanocyte
transplantation. Further long-term examination would be needed
to evaluate possible auto-regulating effect of implanted melano-
cytes on DA levels in parkinsonian models.
In conclusion, we revealed that intrastriatal transplantation of
tyrosinase-expressing melanocytes from the back skin brought
long-lasting amelioration of the apomorphine-induced abnormal
rotation behavior in hemi-PD models. The present results
highlight potentially therapeutic benefits of intrastriatal autograft
cell transplantation of tyrosinase-expressing melanocytes in PD
patients, because the autograft cell transplantation can avoid or
reduce immunological, ethical and social concerns.
Supporting Information
Figure S1 Effects of tyrosinase intrastriatal lipofection
in hemi-parkinsonian rats. (A) Rotation behavior towards
contralateral side for 2 min at 10 min after apomorphine injection
(0.1 mg/kg, s.c.) was recorded at 3, 6 and 12 days after lipofection
of liposome-entrapped tyrosinase (19.2 U/4 mg/4 ml lipofectin
X2) or lipofectin alone into the right lateral striatum of hemi-
parkinsonian rats or sham-operated controls. Values are means 6
SEM of 3–4 rats. *p,0.05, ***p,0.001 vs. each sham-lipofectin,
++p,0.01, +++p,0.001 vs. each 6-OHDA-lipofectin, ###p,0.001
vs. each preinjection of tyrosinase. Representative photographs of
striatal tyrosinase-IR (B) and DA-IR (C) in the tyrosinase-injected
striatal area at day 14 after tyrosinase lipofection in hemi-
parkinsonian rats. (B, C) Each right panel shows means integrated
density of tyrosinase-IR or DA-IR 6 SEM, respectively (n = 3–4).
**p,0.01 vs. intact control side of each treated group.
##p,0.0001 vs. side-matched lipofectin-injected group. +p,0.05
vs. side- and treatment-matched sham-operated group.
(TIF)
Figure S2 Immunostaining of TH in the striatum (A)
and the substantia nigra (B) in hemi-parkinsonian rats
at day 14 after tyrosinase intrastriatal lipofection.
Quantitative data of integrated density of TH-IR in the right
lateral striatal area (C) and substantia nigra pars compacta (D).
Values are means 6 SEM (n= 3). *p,0.05, **p,0.001 vs. intact
control side of each treated group. ++p,0.005 vs. side- and
treatment-matched sham-operated group.
(TIF)
Figure S3 TH-IR in the right lateral striatal area (A) and
the substantia nigra (B) in hemi-parkinsonian rats at 52
days after intrastriatal transplantation of B16-F1 mela-
noma cells. Quantitative data of integrated density of TH-IR in
the striatum around the transplant (C) and substantia nigra pars
compacta (D). Values are means6 SEM (n= 3–4). **p,0.0001 vs.
intact control side of each treated group. ++p,0.0001 vs. side- and
treatment-matched sham-operated group.
(TIF)
Figure 5. Tyrosinase-positive IR (A) and DA-IR (B) in the right
lateral striatum around the transplant of hemi-parkinsonian
albino mice and sham-operated controls at 88 days after
intrastriatal transplantation of melanocytes obtained from
albino (ICR) or black (C57BL) mice. Values are means integrated
density of tyrosinase-IR or DA-IR 6 SEM (n = 3–4). *p,0.005,
**p,0.0001 vs. intact control side of each treated group. #p,0.005,
##p,0.0001 vs. side-matched medium-injected control group.
$p,0.005, $$p,0.0001 vs. side-matched melanocytes from ICR mice-
transplanted group. +p,0.05, ++p,0.0005 vs. side- and treatment-
matched sham-operated.
doi:10.1371/journal.pone.0065983.g005
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Figure S4 TH-IR in the right lateral striatum (A) and the
substantia nigra (B) in hemi-parkinsonian albino mice
at 88 days after intrastriatal transplantation of melano-
cytes obtained from albino (ICR) or black (C57BL) mice.
Quantitative data of integrated density of TH-IR in the right
lateral striatal area around the transplant (C) and substantia nigra
pars compacta (D). Values are means 6 SEM (n= 3–4).
**p,0.0005 vs. intact control side of each treated group.
++p,0.0005 vs. side- and treatment-matched sham-operated
group.
(TIF)
Movie S1 Effects of intrastriatal injection of tyrosinase
on apomorphine-induced rotation behavior in hemi-
parkinsonian rats. Representative movie of behavior at 10 min
after apomorphine injection (0.1 mg/kg, s.c.) at 4 days before (pre-
lipofection) and at 3 days after lipofection of liposome-entrapped
tyrosinase (19.2 U/4 mg/4 ml lipofectin X2) or lipofectin alone
into the right lateral striatum of hemi-parkinsonian rats or sham-
operated controls.
(WMV)
Movie S2 Effects of intrastriatal transplantation of B16-
F1 melanoma cells on apomorphine-induced rotation
behavior in hemi-parkinsonian rats. Representative movie
of behavior at 5 min after apomorphine injection (0.1 mg/kg, s.c.)
on Day 16 after intrastriatal transplantation of B16-F1 melanoma
cell (56105 cells/4 ml PBS X2) into the right lateral striatum of
hemi-parkinsonian rats or sham-operated controls.
(WMV)
Movie S3 Effects of intrastriatal transplantation of
tyrosinase cDNA-transfected human hepatocytes HLE
cells on apomorphine-induced rotation behavior in
hemi-parkinsonian mice. Representative movie of behavior
at 5 min after apomorphine injection (0.5 mg/kg, s.c.) on Day 21
after the transplantation of HLE cells or HLE cells transfected
with tyrosinase cDNA (16106 cells/2 ml PBS) into lesioned side of
lateral striatum in hemi-parkinsonian albino mice or sham-
operated controls.
(WMV)
Movie S4 Effects of intrastriatal transplantation of
primary cultured melanocytes on apomorphine-induced
rotation behavior in hemi-parkinsonian mice. Represen-
tative movie of behavior at 5 min after apomorphine injection
(0.5 mg/kg, s.c.) on Day 14 after the transplantation of
melanocytes from albino ICR or black C57BL mice (36105
cells/2 ml) or MDM medium alone into the right lateral striatum
of hemi-parkinsonian albino mice.
(WMV)
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